New study tracks how CAR-T therapy impacts Seniors' daily lives

NCT ID NCT04300998

First seen Apr 14, 2026 · Last updated Jun 19, 2026 · Updated 9 times

Summary

This study observes older patients (60+) receiving standard CAR-T therapy for blood cancers. Researchers track how treatment affects daily activities, thinking skills, and overall quality of life. No extra treatments are given—just careful monitoring to learn more about patient experiences.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand how CAR-T therapy affects older patients' daily lives and thinking abilities.

What could go wrong

This is an observational study, not a treatment trial. It may not lead to direct improvements in care, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

B-cell neoplasm B-cell non-Hodgkin lymphoma diffuse large B-cell lymphoma high grade B-cell lymphoma lymphoma plasma cell myeloma plasma cell neoplasm refractory hematologic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.